ArticleOpen veterinary journal2025
Carbon nanoparticle toxicity assessment in the liver of male Sprague-Dawley rats.
Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biogenic Metal Nanoparticles from Indian Flora as Programmable Bio-Interfaces: From Phytochemical Coronas to Precision Nanomedicine.International journal of molecular sciences · 2026Review
- Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carbon nanoparticles (CNPs) are extremely small particles mainly composed of carbon atoms, typically ranging from 1 to 100 nm in size. Although CNPs have promising applications in various fields, they can damage cell membranes, cause toxicity, and potentially induce mutations that may lead to cancer. Aim: This study aimed to investigate the dose-dependent effects of CNPs on the liver in rats. Methods: Twenty-five male Sprague-Dawley rats (weight, 100-130 g) were acclimated and randomly divided into five groups. Groups I, II, and III received intraperitoneal injections of CNPs at doses of 19.5, 58.5, and 97.5 mg/kg of body weight for 28 consecutive days, respectively. The saline control group received 0.5 ml of normal saline. Liver samples were collected for biochemical and histological analyses. Results: Rats exposed to higher CNP doses showed significant weight loss. Serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and bilirubin levels were markedly modulated, especially in the high-dose group. Lipid metabolism was also disrupted. Histological studies revealed hepatocellular degeneration, inflammatory infiltration, and sinusoidal dilation at higher CNP concentrations. Conclusion: The results revealed that exposure to CNPs, particularly at higher doses, may lead to liver toxicity and pose health risks. As the use of CNPs becomes more widespread, understanding their biological effects is essential to ensure their safe use for the reasonable development of nanotechnology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.